IntegraGen SA   Report issue

For profit Phase 3
Founded: Evry France (2000)
Status: Left NME R&D (2015)

Organization Overview

First Clinical Trial
2005
NCT03362684
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now

Alternative names

IntegraGen SA

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colorectal Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 4